Chemo/Immunotherapy in Advanced Squamous NSCLC: What is the Impact of IMpower131? (BMIC-026)
Dr. Jack West reviews the preliminary positive result form the IMpower131 trial of chemo +/- atezolizumab immunotherapy and considers what the clinical significance of these findings should be for pat...
Author: BeaconMedIC
Added: 04/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 4, 2018 Category: Cancer & Oncology Source Type: podcasts
May Select Patients for VEGF or PD-1 Targeted Further investigation in other immunotherapies
Walter M. Stadler, MD University of Chicago, discusses how they May Select Patients for VEGF or PD-1 Targeted Further investigation in other immunotherapies at Kidney Cancer Association 2017 in Miami....
Author: kidneycancer
Added: 04/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 3, 2018 Category: Cancer & Oncology Source Type: podcasts
Challenges of VEGF & amp; Immunotherapy Combinations Resistance patterns in patients disease progression
Tian Zhang, MD Duke University Medical Center, explains the Challenges of VEGF & Immunotherapy Combinations Resistance patterns in patients disease progression at Kidney Cancer Association 2017 ...
Author: kidneycancer
Added: 04/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 3, 2018 Category: Cancer & Oncology Source Type: podcasts
The challenges of using biomarkers for immunotherapy
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, from the Winship Cancer Institute, Atlanta, GA, gives a pharmacists perspective on the challenges of using biomarkers in immunotherapy. Using PD-1 and PD-...
Author: VJOncology
Added: 03/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Pharmacist's advice on biomarkers for immunotherapy
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, from the Winship Cancer Institute, Atlanta, GA, discusses the importance of biomarkers in immunotherapy to improve the identification of good and poor resp...
Author: VJOncology
Added: 03/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Reckamp Immunotherapy for Previously Treated Patients with NSCLC [720p]
Dr. Karen Reckamp, MD, MS, Co-Director of the Lung Cancer and Thoracic Oncology Program, Medical Director - Clinical Research Operations, City of Hope Comprehensive Cancer Center in Duarte, California...
Author: cancergrace
Added: 03/25/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 25, 2018 Category: Cancer & Oncology Source Type: podcasts
Pennell The Role for Immunotherapy in Patients with a Driver Mutation [720p]
We are pleased to have Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio share with us 2017 updates for our Lung Cancer ...
Author: cancergrace
Added: 03/25/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 25, 2018 Category: Cancer & Oncology Source Type: podcasts
Should Immunotherapy Stop in Responding Patients After a Fixed Duration of Treatment_ [720p]
<a target='_blank' href='http://cancerGRACE.org/'>http://cancerGRACE.org/...</a>
Author: cancergrace
Added: 03/25/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 25, 2018 Category: Cancer & Oncology Source Type: podcasts
Mar 23, 2018 This Week in Cardiology
His-bundle pacing, Factor Xa reversal, heart failure quality measures, predicting prognosis after cardiac arrest, and myocarditis after cancer immunotherapy are discussed in this week ' s podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 23, 2018 Category: Cardiology Authors: Medscape Source Type: podcasts
Continuing Immunotherapy Beyond Progression. In Which Patients Is This Appropriate [720p]
Lung Cancer Video Library <a target='_blank' href='http://cancerGRACE.org/'>http://cancerGRACE.org/...</a>
Author: cancergrace
Added: 03/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Role for Immunotherapy for Patients with Driver Mutations [720p]
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami, FL) Clinical Associate Professor of Medicine, Herbert Wertheim Coll...
Author: cancergrace
Added: 03/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Multiple Immunotherapy Agents [720p]
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami, FL) Clinical Associate Professor of Medicine, Herbert Wertheim Coll...
Author: cancergrace
Added: 03/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2018 Category: Cancer & Oncology Source Type: podcasts
First Line Immunotherapy for Advanced Non Small Cell Lung Cancer NSCLC [720p]
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami, FL) Clinical Associate Professor of Medicine, Herbert Wertheim Coll...
Author: cancergrace
Added: 03/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2018 Category: Cancer & Oncology Source Type: podcasts
First Line Combinations, Immunotherapy with Chemo [720p]
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami, FL) Clinical Associate Professor of Medicine, Herbert Wertheim Coll...
Author: cancergrace
Added: 03/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Checkpoint inhibitors for lung cancer: combating resistance
Immunotherapy has the potential to provide long-term benefits to certain lung cancer patients; however, certain patients may not respond, while others who initially respond may develop resistance. In ...
Author: VJOncology
Added: 03/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 19, 2018 Category: Cancer & Oncology Source Type: podcasts
